Low	0	3	O
-	3	4	O
level	4	9	O
X	10	11	O
-	11	12	O
radiation	12	21	O
effects	22	29	O
on	30	32	O
functional	33	43	O
vascular	44	52	B-Multi-tissue_structure
changes	53	60	O
in	61	63	O
Syrian	64	70	B-Organism
hamster	71	78	I-Organism
cheek	79	84	B-Tissue
pouch	85	90	I-Tissue
epithelium	91	101	I-Tissue
during	102	108	O
hydrocarbon	109	120	O
carcinogenesis	121	135	O
.	135	136	O

Effects	138	145	O
of	146	148	O
repeated	149	157	O
low	158	161	O
-	161	162	O
level	162	167	O
X	168	169	O
radiation	170	179	O
on	180	182	O
functional	183	193	O
microvascular	194	207	B-Tissue
changes	208	215	O
in	216	218	O
hamster	219	226	B-Organism
cheek	227	232	B-Tissue
pouch	233	238	I-Tissue
epithelium	239	249	I-Tissue
during	250	256	O
and	257	260	O
following	261	270	O
carcinogenesis	271	285	O
by	286	288	O
7	289	290	B-Drug_or_compound
,	290	291	I-Drug_or_compound
12	291	293	I-Drug_or_compound
-	293	294	I-Drug_or_compound
dimethylbenz	294	306	I-Drug_or_compound
[	306	307	I-Drug_or_compound
a	307	308	I-Drug_or_compound
]	308	309	I-Drug_or_compound
anthracene	309	319	I-Drug_or_compound
(	320	321	O
DMBA	321	325	B-Drug_or_compound
)	325	326	O
were	327	331	O
studied	332	339	O
.	339	340	O

Prior	341	346	O
studies	347	354	O
showed	355	361	O
enhancement	362	373	O
of	374	376	O
such	377	381	O
carcinogenesis	382	396	O
by	397	399	O
repeated	400	408	O
20	409	411	O
rad	412	415	O
head	416	420	B-Organism_subdivision
and	421	424	O
neck	425	429	B-Organism_subdivision
X	430	431	O
-	431	432	O
radiation	432	441	O
exposures	442	451	O
,	451	452	O
and	453	456	O
it	457	459	O
was	460	463	O
proposed	464	472	O
that	473	477	O
one	478	481	O
possible	482	490	O
mechanism	491	500	O
was	501	504	O
radiogenic	505	515	O
alteration	516	526	O
of	527	529	O
the	530	533	O
functional	534	544	O
microvasculature	545	561	B-Multi-tissue_structure
in	562	564	O
a	565	566	O
manner	567	573	O
which	574	579	O
favored	580	587	O
subsequent	588	598	O
tumor	599	604	B-Pathological_formation
development	605	616	O
.	616	617	O

Hamsters	618	626	B-Organism
were	627	631	O
treated	632	639	O
with	640	644	O
either	645	651	O
radiation	652	661	O
,	661	662	O
DMBA	663	667	B-Drug_or_compound
,	667	668	O
radiation	669	678	O
+	679	680	O
DMBA	681	685	B-Drug_or_compound
,	685	686	O
or	687	689	O
no	690	692	O
treatment	693	702	O
.	702	703	O

Animals	704	711	O
were	712	716	O
sacrificed	717	727	O
at	728	730	O
3	731	732	O
-	732	733	O
week	733	737	O
intervals	738	747	O
from	748	752	O
0	753	754	O
to	755	757	O
39	758	760	O
weeks	761	766	O
after	767	772	O
treatments	773	783	O
began	784	789	O
.	789	790	O

Pouch	791	796	B-Multi-tissue_structure
vascular	797	805	I-Multi-tissue_structure
volume	806	812	O
and	813	816	O
permeability	817	829	O
changes	830	837	O
were	838	842	O
studied	843	850	O
by	851	853	O
fractional	854	864	O
distributions	865	878	O
of	879	881	O
radiotracers	882	894	O
and	895	898	O
were	899	903	O
analyzed	904	912	O
by	913	915	O
a	916	917	O
variety	918	925	O
of	926	928	O
statistical	929	940	O
methods	941	948	O
which	949	954	O
explored	955	963	O
the	964	967	O
vascular	968	976	O
parameters	977	987	O
,	987	988	O
treatment	989	998	O
types	999	1004	O
,	1004	1005	O
elapsed	1006	1013	O
time	1014	1018	O
,	1018	1019	O
presence	1020	1028	O
of	1029	1031	O
the	1032	1035	O
carcinogen	1036	1046	O
,	1046	1047	O
and	1048	1051	O
histopathologic	1052	1067	O
changes	1068	1075	O
.	1075	1076	O

All	1077	1080	O
treatments	1081	1091	O
resulted	1092	1100	O
in	1101	1103	O
significant	1104	1115	O
changes	1116	1123	O
in	1124	1126	O
vascular	1127	1135	B-Multi-tissue_structure
volume	1136	1142	O
with	1143	1147	O
time	1148	1152	O
,	1152	1153	O
while	1154	1159	O
only	1160	1164	O
DMBA	1165	1169	B-Drug_or_compound
treatments	1170	1180	O
alone	1181	1186	O
resulted	1187	1195	O
in	1196	1198	O
significant	1199	1210	O
changes	1211	1218	O
in	1219	1221	O
vascular	1222	1230	B-Multi-tissue_structure
permeability	1231	1243	O
with	1244	1248	O
time	1249	1253	O
.	1253	1254	O

Prior	1255	1260	O
to	1261	1263	O
the	1264	1267	O
appearances	1268	1279	O
of	1280	1282	O
frank	1283	1288	O
neoplasms	1289	1298	B-Pathological_formation
,	1298	1299	O
volumetric	1300	1310	O
changes	1311	1318	O
in	1319	1321	O
DMBA	1322	1326	B-Drug_or_compound
only	1327	1331	O
and	1332	1335	O
radiation	1336	1345	O
only	1346	1350	O
groups	1351	1357	O
were	1358	1362	O
similar	1363	1370	O
,	1370	1371	O
while	1372	1377	O
volume	1378	1384	O
changes	1385	1392	O
in	1393	1395	O
DMBA	1396	1400	B-Drug_or_compound
+	1401	1402	O
radiation	1403	1412	O
groups	1413	1419	O
increased	1420	1429	O
slowly	1430	1436	O
to	1437	1439	O
a	1440	1441	O
peak	1442	1446	O
later	1447	1452	O
than	1453	1457	O
in	1458	1460	O
other	1461	1466	O
groups	1467	1473	O
and	1474	1477	O
then	1478	1482	O
declined	1483	1491	O
steadily	1492	1500	O
to	1501	1503	O
levels	1504	1510	O
similar	1511	1518	O
to	1519	1521	O
the	1522	1525	O
radiation	1526	1535	O
only	1536	1540	O
group	1541	1546	O
.	1546	1547	O

As	1548	1550	O
in	1551	1553	O
prior	1554	1559	O
studies	1560	1567	O
,	1567	1568	O
there	1569	1574	O
were	1575	1579	O
significant	1580	1591	O
vascular	1592	1600	B-Multi-tissue_structure
volume	1601	1607	O
differences	1608	1619	O
between	1620	1627	O
DMBA	1628	1632	B-Drug_or_compound
and	1633	1636	O
DMBA	1637	1641	B-Drug_or_compound
+	1642	1643	O
radiation	1644	1653	O
groups	1654	1660	O
of	1661	1663	O
tumor	1664	1669	B-Pathological_formation
-	1669	1670	O
bearing	1670	1677	O
cheek	1678	1683	B-Organism_subdivision
pouches	1684	1691	I-Organism_subdivision
.	1691	1692	O

DMBA	1693	1697	B-Drug_or_compound
maxima	1698	1704	O
were	1705	1709	O
significantly	1710	1723	O
higher	1724	1730	O
than	1731	1735	O
those	1736	1741	O
of	1742	1744	O
DMBA	1745	1749	B-Drug_or_compound
+	1750	1751	O
radiation	1752	1761	O
.	1761	1762	O

Radiation	1763	1772	O
significantly	1773	1786	O
affected	1787	1795	O
DMBA	1796	1800	B-Drug_or_compound
-	1800	1801	O
associated	1801	1811	O
vascular	1812	1820	B-Multi-tissue_structure
volume	1821	1827	O
and	1828	1831	O
permeability	1832	1844	O
changes	1845	1852	O
during	1853	1859	O
carcinogenesis	1860	1874	O
.	1874	1875	O

Several	1876	1883	O
possible	1884	1892	O
explanations	1893	1905	O
for	1906	1909	O
the	1910	1913	O
relationship	1914	1926	O
of	1927	1929	O
these	1930	1935	O
changes	1936	1943	O
to	1944	1946	O
the	1947	1950	O
enhancement	1951	1962	O
of	1963	1965	O
DMBA	1966	1970	B-Drug_or_compound
carcinogenesis	1971	1985	O
include	1986	1993	O
:	1993	1994	O
radiation	1995	2004	O
blocking	2005	2013	O
normal	2014	2020	O
capillary	2021	2030	B-Tissue
proliferative	2031	2044	O
and	2045	2048	O
/	2048	2049	O
or	2049	2051	O
dilatory	2052	2060	O
responses	2061	2070	O
to	2071	2073	O
inflammation	2074	2086	O
secondary	2087	2096	O
to	2097	2099	O
neoplastic	2100	2110	O
changes	2111	2118	O
;	2118	2119	O
radiation	2120	2129	O
-	2129	2130	O
induced	2130	2137	O
focal	2138	2143	O
increases	2144	2153	O
in	2154	2156	O
the	2157	2160	O
pericapillary	2161	2174	B-Tissue
connective	2175	2185	I-Tissue
tissue	2186	2192	I-Tissue
histohematic	2193	2205	O
barrier	2206	2213	O
,	2213	2214	O
stimulating	2215	2226	O
angiogenesis	2227	2239	O
but	2240	2243	O
reducing	2244	2252	O
nutrient	2253	2261	O
diffusion	2262	2271	O
;	2271	2272	O
radiation	2273	2282	O
exposures	2283	2292	O
sensitizing	2293	2304	O
vascular	2305	2313	B-Tissue
endothelium	2314	2325	I-Tissue
to	2326	2328	O
subsequent	2329	2339	O
angiogenic	2340	2350	O
stimulation	2351	2362	O
from	2363	2367	O
premalignant	2368	2380	B-Tissue
tissues	2381	2388	I-Tissue
;	2388	2389	O
DMBA	2390	2394	B-Drug_or_compound
vascular	2395	2403	O
and	2404	2407	O
epithelial	2408	2418	O
effects	2419	2426	O
partially	2427	2436	O
or	2437	2439	O
completely	2440	2450	O
blocking	2451	2459	O
radiation	2460	2469	O
effects	2470	2477	O
on	2478	2480	O
epithelial	2481	2491	B-Cell
and	2492	2495	O
/	2495	2496	O
or	2496	2498	O
endothelial	2499	2510	B-Cell
cells	2511	2516	I-Cell
;	2516	2517	O
and	2518	2521	O
radiation	2522	2531	O
damage	2532	2538	O
to	2539	2541	O
vessel	2542	2548	B-Multi-tissue_structure
walls	2549	2554	I-Multi-tissue_structure
partially	2555	2564	O
or	2565	2567	O
fully	2568	2573	O
inhibiting	2574	2584	O
normal	2585	2591	O
physiologic	2592	2603	O
mechanisms	2604	2614	O
of	2615	2617	O
repairing	2618	2627	O
DMBA	2628	2632	B-Drug_or_compound
damage	2633	2639	O
to	2640	2642	O
the	2643	2646	O
vessels	2647	2654	B-Multi-tissue_structure
.	2654	2655	O

